Australians deserve fast access to the latest medicines, vaccines and treatments

28 January 2022 - Medicines Australia recommends the Australian Government delivers a plan to shorten the time that patients wait ...

Read more →

mRNA manufacturing facility will deliver long term health benefits for Australians

14 December 2021 - Medicines Australia welcomes the announcement that Australia will manufacture mRNA vaccines in a deal struck with ...

Read more →

Forecast 2 for the 2021 rebate from side agreements

13 December 2021 - In a new report to the government, TLV forecasts that the pharmaceutical companies will pay approximately ...

Read more →

‘All I want for Christmas’ is higher prices: Congressional report accuses pharma of manipulating Americans for profit

10 December 2021 - It was the day before Christmas in 2015 and a senior director of national accounts at ...

Read more →

Additional insights from the agenda for the March 2022 PBAC meeting

26 November 2021 - More insights from the MAESTrO Team. ...

Read more →

Drugmakers gear up for price restrictions in Biden’s legislative agenda

25 November 2021 - Industry potentially faces significant expansion of government regulation despite success in watering down Democratic proposals. ...

Read more →

PhRMA statement on Democrats' drug pricing deal in reconciliation package

2 November 2021 - The following can be attributed to PhRMA President and CEO Stephen J. Ubl. ...

Read more →

The risks of government negotiation of drug prices

25 October 2021 - Under the guise of Medicare ‘negotiations,’ the US House of Representatives is considering a measure that would ...

Read more →

Drug pricing reform opponents win most pharma lobbying money

26 October 2021 - Democratic Party law makers holding up proposed drug pricing reforms are among the largest beneficiaries of the ...

Read more →

Pharmaceutical industry backs workplace vaccinations

5 October 2021 - Medicines Australia strongly recommends full COVID-19 vaccinations for the health and safety and protection of all ...

Read more →

Medicines industry continues to protect Australians from medicine shortages

30 September 2021 - ACCC extends approval for ongoing collaboration ...

Read more →

Manufacturers’ perceptions of the decision-making process for new drug reimbursement in South Korea

17 September 2021 - This study aimed to evaluate manufacturers’ perceptions of the decision-making process for new drug reimbursement and to ...

Read more →

MSD Australia endorses new medicines strategic agreement

8 September 2021 - MSD Australia has today welcomed the signing of a new Medicines Strategic Agreement between Medicines Australia ...

Read more →

Landmark new medicines agreements to bring significant benefits for Australian patients

7 September 2021 - Australians will have more affordable, improved and guaranteed access to medicines under landmark long-term strategic agreements between ...

Read more →

New strategic agreements with the medicines industry

7 September 2021 - The Australian Government has entered into new strategic agreements with Medicines Australia and the Generic and ...

Read more →